The use of smart technology has established a smart presence in the healthcare domain. This has led to an increased number of smart devices. Market focused reports linked with the healthcare industry among others recently have been made available by Market Research Future which issues reports on this industry. The Smart Inhalers Market globally is projected to expand with a 42.8 percent CAGR approximately while earning revenues worth $1636.1 million by the end of the forecast period.
The need to monitor medicine dosage and schedule the medicine intake the market for smart inhalers has grown considerably. Due to the prevalence of ailments like asthma, the market has grown considerably over the past few years. As asthma patients are required to monitor their drug intake diligently, the smart inhalers provide a great degree of convenience in that regard. The development of the market is also powered by the incorporation of cutting-edge technologies in these products.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2117
Global Smart Inhalers Market – Key Players
Adherium Limited (New Zealand), AstraZeneca (England), Cohero Health (USA), GlaxoSmithKline (U.K.), Gecko Health Innovations Inc (USA), Inspiro Medical Ltd., and Propeller Health (USA) are some of the prominent players at the forefront of competition in the Global Smart Inhalers Market and are profiled in MRFR Analysis.
Latest Industry News:
Adherium’s partnering and market expansion for the ‘Rest of World’ territories, including countries in Asia Pacific and the Middle East where Adherium already has sanctions to market its Smartinhaler products in China, Australia and New Zealand. This will increase the company’s strength in these countries.
Moreover, AstraZeneca, multinational pharmaceutical and biopharmaceutical Company had recently started its expansion in respiratory business with the acquisition of respiratory business of Tadeka Pharmaceuticals in 2016, and also with partnership with Adherium, for the supplies of smart inhaler and sensors.
In January 2017, AstraZeneca announced that on 25 January 2017 the US Food and Drug Administration (FDA) granted six months of paediatric exclusivity for Symbicort (budesonide/formoterol) Inhalation Aerosol. Symbicort is approved in the US to treat asthma in patients 12 years and older and for the maintenance and treatment of COPD in adults, the company is expecting larger market share with the product launch.
Gecko Health Innovations, Inc., acquired by Teva Pharmaceutical in 2015, focusing on cloud-based solution to simplify chronic respiratory disease management, and connect patients and caregivers through remote monitoring and real-time tools. The major driving factors for the company’s growth in the market are due to increasing technological advancements and need for integrated cloud-based technologies in the treatment of respiratory diseases.
Global Smart Inhalers Market – Key Finding
- The Smart Inhalers global market and is expected to reach $1636.1 million by 2022.
- Dry Powder Inhalers hold the largest share of the market.
- North America holds the largest market share of 54.3% of smart inhalers market and is anticipated to reach $888.4 million by the end of forecast period.
- Globally, Asia-Pacific the fastest growing region and expected to grow at the rate of 55.3% during the forecast period.
Global Smart Inhalers Market – Segments
Smart Inhalers Market has been segmented on the basis of type which comprises of dry powder inhaler, and metered dose inhaler. On the basis of application, market is segmented into Asthma, COPD, and others. On the basis of end user, market is segmented into hospitals & clinics, respiratory care center, and others.
Browse Complete 81 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/smart-inhalers-market-2117
Global Smart Inhalers Market – Regional Analysis
Globally North America is the largest market for Smart Inhalers which is anticipated to reach $888.4 million by 2023. Europe is the second-largest market in 2016 which is valued at $57.4 million. Furthermore, Asia pacific market is expected to be the fastest growing market and is projected to grow at a CAGR of 55.3% during the forecast period from 2016-2022. Smart inhalers market in rest of world is expected to rise after 2019.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com